NASH market to increase forty-fold by 2026

NASH market to increase forty-fold by 2026

by | May 16, 2017 | News

Juliet Preston May 16, 2017 A new report by GlobalData has underscored the extreme blockbuster potential of fatty liver disease and non-alcoholic steatohepatitis (NASH), projecting that the current $618 million market will balloon to $25.3 billion by 2026. A new...
Early Study to Test Bioelectronic Treatment for NASH

Early Study to Test Bioelectronic Treatment for NASH

by | May 15, 2017 | News

Inês Martins, PhD May 15, 2017 A pre-clinical study to evaluate the therapeutic potential of a bioelectronic platform in preventing and reducing inflammation in non-alcoholic steatohepatitis (NASH) is beginning, its developer, Endonovo Therapeutics, announced. This is...